Abstract
antihypertensive treatment according to the guidelines of the and standard deviation. Means were compared by ANOVA.
All statistical analyses were carried out with the statistical German Hypertension League.
package SPSS 6.0 for Windows. Hardy-Weinbergequilibrium was tested using the 'hwe'-function of the Methods linkage package. A P value <0.05 was regarded as significant. We examined a polymorphism in intron 2 of the ANP gene [7] in patients with type I and type II diabetes. This polymorphism can be detected using PCR amplification of the Results DNA followed by restriction digest with Hpa II. patients with and without diabetic nephropathy primer 1: 5∞-GGC ACA CTC ATA CAT GAA GCT GAC ( Table 2 ).
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In addition we genotyped patients with type I diabetes for a second polymorphism in the ANP gene. The ScaI polymorphism is located in the stop-codon Reaction mix (total volume 50 ml ): 200 ng DNA, of the gene. But also for this polymorphism as well no 10×OptiPerformTM buffer III (500 mM OptiperformTM-difference in genotype distribution or allele frequencies KOH pH 9.2, 160 mM (NH 4 )SO 4 , 0.1% Tween 20), 1.5 mM was observed ( Table 2) .
MgCl 2 , 5×OptiZymeTM-enhancer, 10 pmol of each primer, 0.2 mM dNTP, 1 Unit CombiPolTM DNA Polymerase Mix (InViTek, Berlin/Germany).
Patients with extremes of renal risk
The DNA was amplified according to a two-step protocol:
In a subanalysis we compared patients with maximally after initial denaturation, 30 cycles of 94°C 30 s, 70°C 1 min contrasting renal risk, i.e. those who were normotensive 30 s; 10 ml of the amplicon were digested with 3U Sca I at and normoalbuminuric, with patients who had pro-37°C overnight. Alleles were separated on 2.5% Metaphor (FMC distribution or in allele frequencies, but again a trend pathy ( Table 3) . Similarly, no difference in allele frequencies or genotype distribution was observed towards a lower frequency of the H1H2-genotype and H1-allele was observed in patients with type I diabetes analysing the ScaI-polymorphism in patients with type I diabetes ( Table 3) . without nephropathy compared to those with nephro-
